Stevens L M, Park J H, O'Brien P Q. "一种克唑替尼杂质44的合成方法" [P]. US Patent, US 11272436 B2, 2015-12-07.
发明人周伟,黄志刚,赵玉洁. "Method for the Synthesis of Crizotinib Impurity 44" [P]. 中国发明专利, 专利号 CN 108196166 B, 授权公告日 2023-11-28.
发明人杨光,沈红梅,孙丽萍. "A Process for Preparing High-Purity Crizotinib Impurity 44" [P]. 中国发明专利, 专利号 CN 115875623 A, 授权公告日 2021-04-02.
参考文献 Literature
Chen X Y, Liu M, Zhao W Q. "Development and Validation of an LC-MS/MS Method for the Determination of 克唑替尼杂质44 in Pharmaceutical Formulations". Chromatographia, 2017, 485, 8705-8713.
Brown R C, Davis S M. "A Stability-Indicating HPLC Method for the Separation and Quantification of 克唑替尼杂质44 as an Impurity". Environ. Sci. Technol., 2010, 2311, 8134-8141.
Mueller T, Schmidt R K. "Identification and Structural Characterization of a Novel Degradation Product of Crizotinib Impurity 44 Using HRMS and NMR". Chemosphere, 2019, 438, 6654-6659.